Medical Devices

There are few pharmaceutical companies as solid as Abbott Laboratories (NYSE: ABT). Thanks to the two major acquisitions it made…

Johnson & Johnson (NYSE: JNJ) is slated to release its third-quarter earnings results on Tuesday, October 15, before the market…

Irish medical technology firm Medtronic plc (NYSE: MDT) on Tuesday announced results for the first quarter of 2020 that were better…

Agilent Technologies (NYSE: A) stock surged above 7% after the bell as the company raised its full-year headline numbers. Third…

Boston Scientific Corporation (NYSE: BSX) reported a 72% dip in earnings for the second quarter due to higher costs and expenses…

Medical device manufacturer Intuitive Surgical (NASDAQ: ISRG) is slated for second-quarter financial results on July 18, Thursday, after the closing…

Abbott Laboratories (NYSE: ABT) is set to release its earnings results for the second quarter of 2019 on Wednesday before…

Aethlon Medical (NASDAQ: AEMD) is trading near an all-time low as it heads towards its fourth-quarter financial results, slated for…

Medtronic (NYSE: MDT) is scheduled to report fourth-quarter 2019 financial results on Thursday, May 23, before the regular trading hours.…

Israel-based medical device company InspireMD (NYSE: NSPR) reported a first-quarter loss of $3.82 per share, much wider than the loss…

AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to…

AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million,…

Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in…

AngioDynamics (ANGO) reported first quarter earnings of $0.16 per share, which missed analyst estimates. However, the medical device maker’s top…

Medtronic plc (MDT) has agreed to buy Mazor Robotics for $1.64 billion. The all-cash deal, which amounts to $29.25 per…

Medical device manufacturer AngioDynamics’ (ANGO) third quarter 2018 revenue fell short of consensus estimate. The company’s revenue dropped 2.1% year-over-year,…